 |
ST. PAUL, Minn., July 30, 2025 /PRNewswire/ -- In a significant development in an ongoing legal dispute, the U.S. Patent and Trademark Office (USPTO) has issued a final rejection of all claims in U.S. Patent No. 11,660,056 held by Rampart IC, LLC related to a radiation shielding device. The decision follows a request for reexamination by Egg Medical, Inc., which argued that Rampart's '056 patent covered technology that had already been invented—some examples dating as far back as the 1960s.
Egg Medical's reexamination request arose out of a lawsuit that Rampart filed in federal court in 2024, in which Rampart alleged that Egg Medical had infringed on its '056 patent. However, after the USPTO twice rejected all claims in the '056 patent, the federal judge overseeing the case stayed the proceedings pending the outcome of the reexamination. In July 2025, the USPTO issued a final rejection of all claims, citing multiple prior inventions—two of which were developed by Egg Medical.
"The remarkable part of this lawsuit is that Egg Medical never sold any product that fell within the scope of Rampart's now-rejected patent claims," said Robert F. Wilson, MD, CEO of Egg Medical. "Egg Medical respects prior intellectual property. The USPTO rejecting the claims in Rampart's asserted '056 patent validates what we have been saying all along."
Gavin Philipps, Chief Commercial Officer at Egg Medical, added, "The lawsuit was harmful to our company, as Rampart's sales team at times suggested to customers that we were infringing on their '056 patent—an assertion that was never true. We're pleased that the USPTO has thoroughly and repeatedly rejected all of Rampart's claims in that patent, and we're glad our customers now have clarity."
Rampart IC may still respond to the USPTO's final rejection or appeal to the Patent Trial and Appeal Board. After three rounds and a sweeping final rejection, however, Rampart's options are dwindling.
About Egg Medical
Egg Medical is a global leader in radiation protection, founded with the goal to reduce the radiation exposure of healthcare workers who use x-ray imaging to perform life-saving diagnostic and therapeutic procedures for patients. More information about Egg Medical is available at https://eggmedical.com.
ST. PAUL, Minn., July 30, 2025 /PRNewswire/ -- In a significant development in an ongoing legal dispute, the U.S. Patent and Trademark Office (USPTO) has issued a final rejection of all claims in U.S. Patent No. 11,660,056 held by Rampart IC, LLC related to a radiation shielding device. The decision follows a request for reexamination by Egg Medical, Inc., which argued that Rampart's '056 patent covered technology that had already been invented—some examples dating as far back as the 1960s.
Egg Medical's reexamination request arose out of a lawsuit that Rampart filed in federal court in 2024, in which Rampart alleged that Egg Medical had infringed on its '056 patent. However, after the USPTO twice rejected all claims in the '056 patent, the federal judge overseeing the case stayed the proceedings pending the outcome of the reexamination. In July 2025, the USPTO issued a final rejection of all claims, citing multiple prior inventions—two of which were developed by Egg Medical.
"The remarkable part of this lawsuit is that Egg Medical never sold any product that fell within the scope of Rampart's now-rejected patent claims," said Robert F. Wilson, MD, CEO of Egg Medical. "Egg Medical respects prior intellectual property. The USPTO rejecting the claims in Rampart's asserted '056 patent validates what we have been saying all along."
Gavin Philipps, Chief Commercial Officer at Egg Medical, added, "The lawsuit was harmful to our company, as Rampart's sales team at times suggested to customers that we were infringing on their '056 patent—an assertion that was never true. We're pleased that the USPTO has thoroughly and repeatedly rejected all of Rampart's claims in that patent, and we're glad our customers now have clarity."
Rampart IC may still respond to the USPTO's final rejection or appeal to the Patent Trial and Appeal Board. After three rounds and a sweeping final rejection, however, Rampart's options are dwindling.
About Egg Medical
Egg Medical is a global leader in radiation protection, founded with the goal to reduce the radiation exposure of healthcare workers who use x-ray imaging to perform life-saving diagnostic and therapeutic procedures for patients. More information about Egg Medical is available at https://eggmedical.com.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Egg Medical Announces U.S. Patent and Trademark Office Issues Final Rejection of All Claims in Rampart IC's Radiation Shield Patent Following a Reexamination Challenge
LAS VEGAS, Jan. 16, 2026 /PRNewswire/ -- During CES 2026, Infinix, an innovation-driven technology brand, captured the global spotlight, winning the Innovation Award 2026 from internationally authoritative tech media Trusted Reviews, the "Best of CES 2026" title from renowned veteran tech outlet Android Headlines, as well as multiple "Best of CES 2026" honors from leading mainstream technology media. The accolades highlight industry recognition of Infinix's latest innovations across satellite communication, sustained performance, personalized expression, and AI ecosystem products.
Centered on the theme "Joy Tech, Beyond Limit," Infinix showcased a series of breakthrough technologies that redefine connectivity, sustained performance, and personalized expression, ushering in a new era of mobile innovation. The highlight was Infinix's first seamless two-way satellite communication solution, bringing satellite connectivity to consumer-grade smartphones in an unprecedented way and further expanding the boundaries of network versatility. Powered by a high-performance satellite modem, the system delivers two-way voice and messaging across nearly two-thirds of the Earth's surface, with seamless automatic switching between terrestrial and satellite networks. This technology will make its commercial debut in the upcoming Infinix NOTE 60 Series, bringing high-end connectivity to a broader global audience.
Other major innovations include industry-leading thermal efficiency achieved through the HydroFlow Liquid Cooling Architecture and Piezoelectric Fan integrated directly into the smartphone's thermal path, overcoming the physical limits of passive cooling and ensuring stable high performance even under heavy loads, delivering an exceptional mobile gaming experience. The Active Visual Backplate Technology turns the smartphone backplate into a dynamic visual canvas without drawing additional power. Its patterns and colors shift with viewing angle, temperature, and lighting, while also offering continuous animations and glass-free 3D effects. The Infinix AI GLASSES Pro features a dual-chip architecture, enabling high-performance first-person capture and comprehensive, low-power intelligent interaction. The AI Module, a magnetic expansion ecosystem, evolves the smartphone into an AI creative hub, showcasing Infinix's vision for the future intelligent ecosystem.
Throughout the event, the Infinix showcase became a hub for global tech media, attracting coverage from The Verge, Wired, ZDNet, GSMArena, Gizmochina, Stuff, Android Police, and more, while earning authoritative "Best of CES 2026" honors across multiple categories:
As the curtains fall on CES 2026, Infinix will continue to champion the "Joy Tech, Beyond Limit" philosophy, exploring the limitless possibilities of technology and pushing the boundaries of connectivity, creativity, and freedom in smart devices. By bridging forward-looking concepts with real-world applications, Infinix is setting a new benchmark for the smartphone ecosystem, ensuring that every innovation delivers a more connected, creative, and liberating experience for users worldwide.
About Infinix
Established in 2013, Infinix is an innovation-driven brand dedicated to delivering cutting-edge technology, bold design, and outstanding performance. The brand provides smart, enjoyable mobile experiences that enhance everyday life. Beyond smartphones, Infinix has expanded its portfolio to include TWS earbuds, smartwatches, laptops, tablets, smart TVs, and more — building a comprehensive ecosystem of smart devices. Currently, Infinix products are available in over 70 countries and regions worldwide, including Africa, Latin America, the Middle East, South Asia, and Southeast Asia.
For more information, please visit: http://www.infinixmobility.com/
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Infinix Wins Multiple "Best of CES 2026" Awards for Satellite Communication and Breakthrough Innovations
Infinix Wins Multiple "Best of CES 2026" Awards for Satellite Communication and Breakthrough Innovations
